In human lung cancer cell line PC9 with Glu746-Ala750 deletion mutation in exon 19 of EGFR, gefitinib inhibited phosphorylated Akt (p-Akt) and phosphorylated mTOR (p-mTOR) expression [77]. Here, AKT1 is linked to lung carcinoma.